Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice

Cardiology (Switzerland)

Volumn 130, Issue 3, 2015, Pages 175-184

  Ren, Jiling ^a   Yang, Lei ^b   Tian, Wencong ^b   Zhu, Mengmeng ^b   Liu, Jie ^b   Lu, Ping ^a   Li, Jing ^b   Yang, Liang ^b   Qi, Zhi ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; Endothelial nitric oxide synthase; Exercise training; L NAME; Nitric oxide

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXERCISE; FEMALE; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; CARDIOMEGALY; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ECHOCARDIOGRAPHY; FIBROSIS; GENETICS; HEART MUSCLE; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ENZYME INHIBITORS; FEMALE; FIBROSIS; ISOPROTERENOL; MICE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84924132344     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000370025     Document Type: Article

References (28)

1. Serra AJ, Higuchi ML, Ihara SS, Antonio EL, Santos MH, Bombig MT, Tucci PJ: Exercise training prevents beta-adrenergic hy-peractivity-induced myocardial hypertrophy and lesions. Eur J Heart Fail 2008; 10: 534-539.
2. Serra AJ, Santos MH, Bocalini DS, Antonio EL, Levy RF, Santos AA, Higuchi ML, Silva JA, Magalhaes FC, Barauna VG, et al: Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyper-activity. J Physiol 2010; 588:2431-2442.
3. Giannuzzi P, Temporelli PL, Corra U, Tavazzi L; ELVD-CHF Study Group: Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 2003; 108:554-559.
4. Andersen K, Jonsdottir S, Sigurethsson AF, Sigurethsson SB: The effect of physical training in chronic heart failure (in Icelandic). Laeknabladid 2006; 92:759-764.
5. 2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension 2003; 41:963-967.
6. Linz W, Wohlfart P, Scholkens BA, Malinski T, Wiemer G: Interactions among ACE, kinins and NO. Cardiovasc Res 1999; 43:549-561.
7. Matsuoka H, Nakata M, Kohno K, Koga Y, Nomura G, Toshima H, Imaizumi T: Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 1996; 27:14-18.
8. Ozaki M, Kawashima S, Yamashita T, Hirase T, Ohashi Y, Inoue N, Hirata K, Yokoyama M: Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J 2002; 66:851-856.
9. Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL: Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-ad-renergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation 2004; 110:2666-2672.
10. Jones SP, Greer JJ, van Haperen R, Duncker DJ, de Crom R, Lefer DJ: Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 2003; 100:4891-4896.
11. Napoli C, Williams-Ignarro S, De Nigris F, Lerman LO, Rossi L, Guarino C, Mansueto G, Di Tuoro F, Pignalosa O, De Rosa G, et al: Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004; 101: 8797-8802.
12. Calvert JW, Condit ME, Aragon JP, Nicholson CK, Moody BF, Hood RL, Sindler AL, Gundewar S, Seals DR, Barouch LA, Lefer DJ: Exercise protects against myocardial isch-emia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitro-sothiols. Circ Res 2011; 108:1448-1458.
13. Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O, et al: Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003; 41:99-107.
14. Yang L, Jia Z, Zhu M, Zhang J, Liu J, Wu P, Tian W, Li J, Qi Z, Tang X: E xercise protec ts against chronic beta-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase. PLoS One 2014; 9:e96892.
15. Drexler H: Nitric oxide synthases in the failing human heart: a doubled-edged sword? Circulation 1999; 99:2972-2975.
16. Krenek P, Kmecova J, Kucerova D, Bajuszova Z, Musil P, Gazova A, Ochodnicky P, Klimas J, Kyselovic J: Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. Eur J Heart Fail 2009; 11:140-146.
17. Zhang P, Xu X, Hu X, van Deel ED, Zhu G, Chen Y: Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 2007; 100: 1089-1098.
18. Hu A, Jiao X, Gao E, Koch WJ, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ: Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking in-ducible nitric-oxide synthase-mediated nitra-tive stress. J Pharmacol Exp Ther 2006; 318: 469-475.
19. Quindry JC, French J, Hamilton KL, Lee Y, Selsby J, Powers S: Exercise does not increase cyclooxygenase-2 myocardial levels in young or senescent hearts. J Physiol Sci 2010; 60: 181-186.
20. ω-nitro-L-arginine methyl ester induced hypertension and renal dysfunction. J Ethnopharmacol 2012; 142: 467-473.
21. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992; 20:298-303.
22. Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B: Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br J Pharmacol 1996; 118: 1433-1440.
23. Kuru O, Senturk UK, Kocer G, Ozdem S, Baskurt OK, Cetin A, Yesilkaya A, Gunduz F: Effect of exercise training on resistance arteries in rats with chronic NOS inhibition. J Appl Physiol (1985) 2009; 107:896-902.
24. Vergely C, Perrin-Sarrado C, Clermont G, Rochette L: Postischemic recovery and oxida-tive stress are independent of nitric-oxide synthases modulation in isolated rat heart. J Pharmacol Exp Ther 2002; 303:149-157.
25. Sampaio RC, Tanus-Santos JE, Melo SE, Hys-lop S, Franchini KG, Luca IM, Moreno H Jr: Hypertension plus diabetes mimics the car-diomyopathy induced by nitric oxide inhibition in rats. Chest 2002; 122:1412-1420.
26. Suda O, Tsutsui M, Morishita T, Tanimoto A, Horiuchi M, Tasaki H, Huang PL, Sasaguri Y, Yanagihara N, Nakashima Y: Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice. Circulation 2002; 106:1729-1735.
27. Darblade B, Batkai S, Causse E, Gourdy P, Fouque MJ, Rami J, Arnal JF: Failure of L-ni-troarginine to inhibit the activity of aortic in-ducible nitric oxide synthase. J Vasc Res 2001; 38:266-275.
28. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, Christopher TA, Ma XL: Nitric oxide mediates the antiapoptotic effect of insulin in myo-cardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide syn-thase phosphorylation. Circulation 2002; 105: 1497-1502.